Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-24-030963
Filing Date
2024-04-05
Accepted
2024-04-05 21:45:31
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 7540
  Complete submission text file 0001213900-24-030963.txt   8918
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Issuer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 LINCOLN ROAD SUITE 500 MIAMI BEACH FL 33139
Business Address
Marques Tiago (Reporting) CIK: 0001875240 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40804 | Film No.: 24827971